+44 (0) 1698 534002
Contact
About Us
About BioAscent
Company Video
Board
Management Team
Scientific Team
Awards
Testimonials
Our Values
Our Site
Read more
Integrated Drug Discovery
Overview
Integrated drug discovery projects
Protein Production
Biochemical, Biophysical & Cellular Assay Development
GPCR Drug Discovery
Target analysis & bespoke screening strategies
Compound Screening
Surface Plasmon Resonance (SPR) & Biophysics
In Silico Discovery and Data Analysis
Physicochemical Profiling & DMPK
Medicinal Chemistry
Synthetic Chemistry
External library selection & sourcing
In-house Diversity and Fragment Libraries
Compound Management
Resources
Case Studies
Publications
Posters
News & Events
News
Events
Careers
About Us
- About BioAscent
- Company Video
- Board
- Management Team
- Scientific Team
- Awards
- Testimonials
- Our Values
Integrated Drug Discovery
- Overview
- Integrated drug discovery projects
- Protein Production
- Biochemical, Biophysical & Cellular Assay Development
- GPCR Drug Discovery
- Target analysis & bespoke screening strategies
- Compound Screening
- Surface Plasmon Resonance (SPR) & Biophysics
- In Silico Discovery and Data Analysis
- Physicochemical Profiling & DMPK
- Medicinal Chemistry
- Synthetic Chemistry
- External library selection & sourcing
- In-house Diversity and Fragment Libraries
Compound Management
Resources
- Case Studies
- Publications
- Posters
News & Events
- News
- Events
Careers
Posters
The European Lead Factory: A Collaborative Approach to Drug Discovery
Go to poster
The SULSA Assay Development Fund: a model for widening access to high throughput screening
Go to poster
Characterization of small molecule inhibitors of the Nrf2-Keap1 interaction using MicroScale Thermophoresis
Go to poster
The use of Dynamic Mass Redistribution (DMR) in the European Lead Factory (ELF): a case study
Go to poster
Using a library of Pan-Assay Interference (PAINS) small molecules to understand and improve HTS outcomes
Go to poster
Using label-free technologies to characterise the pharmacology of the mas-related GPCR family member D (MRGPRD) receptor
Go to poster
Discovery and Characterisation of a Novel TRPML1 Agonist
Go to poster
Advancing Drug Discovery: Facilitating AI-driven Initiatives with Automation in BioAscent’s Centralised Compound Management
Go to poster
Integrated Drug Discovery
Science-led drug discovery
Compound Management
Connecting and accelerating your drug discovery
Medicinal Chemistry
Proven expertise in design and synthesis
In Silico Discovery
Accelerating drug design with computational expertise
Discovery Biology
Screening expertise across target classes
Get in Touch
Let's talk about how we can maximise your drug discovery success.
Contact
)
)
)
)
)
)
)
)
